HealthNotableConfirmedDeveloping
5.9
Gene-editing therapy demonstrates sustained LDL cholesterol reduction in one-year clinical trial
New York Times·US·about 8 hours ago
Startup Archo Medical is seeking $5-10 million in capital to advance research into endovascular disease treatments, specifically aortic interventions. The funding round targets financial investors and healthcare firms, marking a transition to a new development phase following successful initial implants.